The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 17,201–17,300 of 31,469
Giussani, M., Orlando, A., Tassistro, E., Lieti, G., Patti, I., Antolini, L., Parati, G., & Genovesi, S. (2022) · Nutrients · doi:10.3390/nu14051034 · Cited by 17
Konończuk, K., Muszyńska-Rosłan, K. M., Konstantynowicz-Nowicka, K., Krawczuk‐Rybak, M., Chabowski, A., & Latoch, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073712 · Cited by 17
Wang, G., Li, X., Zhou, Y. Q., Feng, J., & Zhang, M. (2022) · Animals · doi:10.3390/ani12070844 · Cited by 17
Shen, J., Yu, H., Li, K., Ding, B., Xiao, R., & Ma, W. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s353449 · Cited by 17
Lindegaard, B., Hvid, T., Mygind, H. W., Mortensen, O. H., Grøndal, T., Abildgaard, J., Gerstoft, J., Pedersen, B. K., & Baranowski, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0186755 · Cited by 16
Nah, E., Cho, S., Park, H., Kim, S., & Cho, H. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24454 · Cited by 16
Adipose tissue LECT2 expression is associated with obesity and insulin resistance in K orean women
Kim, J., Lee, S. K., Kim, D., Lee, E., Park, C. Y., Choe, H., Kang, M., Kim, H. J., Kim, J., Hong, J. P., et al. (2022) · Obesity · doi:10.1002/oby.23445 · Cited by 16
Candidate biomarkers of physical frailty in heart failure: an exploratory cross-sectional study
Denfeld, Q. E., Purnell, J. Q., Lee, C. S., ORWOLL, E. S., Camacho, S. A., Hiatt, S. O., Davis, M. C., Winters‐Stone, K. M., Woodward, W. R., & Habecker, B. A. (2022) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvac054 · Cited by 16
Zhang, W., Jia, X.-Z., Xu, Y.-H., Xie, Q.-L., Zhu, M.-F., Zhang, H., Zhao, Z.-F., Hao, J., Li, H., Du, J., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.939423 · Cited by 17
Guedes, D. P., & Zuppa, M. A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19148798 · Cited by 21
Rennie, K., Witham, M. D., Bradley, P., Clegg, A. P., Connolly, S., Hancock, H. C., Hiu, S. K. W., Marsay, L., McDonald, C., Robertson, L., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061823 · Cited by 16
Azab, E. F. E., & Abdulmalek, S. A. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4812993 · Cited by 16
Hwang, S. E., Kwon, H., Yun, J. M., Min, K., Kim, H., & Park, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-23324-4 · Cited by 17
Evening chronotype is associated with hormonal and metabolic disorders in polycystic ovary syndrome
Barrea, L., Verde, L., Vetrani, C., Docimo, A., de Alteriis, G., Savastano, S., Colao, A., & Muscogiuri, G. (2022) · Journal of Pineal Research · doi:10.1111/jpi.12844 · Cited by 22
Yi, Y., Wang, C., Ding, Y., He, J., Lv, Y., & Chang, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1101892 · Cited by 21
Lim, S. H., Kim, D., Kang, J. H., Song, J. H., Yang, S. Y., Yim, J. Y., Chung, S. J., Kim, J. S., & Cho, S. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12841 · Cited by 16
Novel effects of rosiglitazone on SMAD2 and SMAD3 signaling in white adipose tissue of diabetic rats
Beaudoin, M., Snook, L. A., Arkell, A. M., Stefanson, A. L., Wan, Z., Simpson, J. A., Holloway, G. P., & Wright, D. C. (2014) · Obesity · doi:10.1002/oby.20717 · Cited by 16
Jiménez-Domínguez, G., Blé‐Castillo, J. L., Aparicio-Trápala, M. A., Juárez‐Rojop, I. E., Tovilla‐Zárate, C. A., Ble-Castillo, D. J., García-Vázquez, C., Olvera‐Hernández, V., Pérez-Pimienta, B., Díaz-Zagoya, J. C., et al. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120707491 · Cited by 16
Shen, Q., & Bergquist‐Beringer, S. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12044 · Cited by 17
Cordeiro, A., Pereira, S., Saboya, C. J., & Ramalho, A. (2015) · BioMed Research International · doi:10.1155/2015/839253 · Cited by 16
Riggio, S., Mamone, F., Mandraffino, G., Maimone, S., Alibrandi, A., Manti, L., Saitta, C., Tripodi, P. F., Sardo, M. A., Squadrito, G., et al. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02323.x · Cited by 16
Terazawa-Watanabe, M., Tsuboi, A., Fukuo, K., & Kazumi, T. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0023 · Cited by 16
Impaired PI3 K Akt expression in liver and skeletal muscle of ovariectomized rats
Wang, Y., Li, B., Zhang, W., Liu, Y., Xue, P., Ma, J., & Li, Y. (2013) · Endocrine · doi:10.1007/s12020-013-9894-1 · Cited by 16
Ko, J. M., Park, H. K., Yang, S., Kim, E. Y., Chung, S. C., & Hwang, I. T. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej11-0358 · Cited by 16
Effects of combined exercise on HOMA-IR, HOMA β-cell and atherogenic index in Korean obese female
Ha, C. H., Swearingin, B., Jeon, Y. K., & Lee, M. (2014) · Sport Sciences for Health · doi:10.1007/s11332-014-0208-7 · Cited by 16
Kaji, N., Okuno, A., OHNO-ICHIKI, K., Oki, H., ISHIZAWA, H., Shirai, M., & Fumitoshi, A. S. A. I. (2012) · Journal of Veterinary Medical Science · doi:10.1292/jvms.12-0045 · Cited by 16
Sakou, I.-I., Ψαλτοπούλου, Θ., Sergentanis, T. Ν., et al. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0431 · Cited by 16
Gómez, J. M., Sahún, M. J. S., Vila-Coll, R., Domenech, P., Catalina, P. F., Soler, J., & Badimón, L. (2007) · Current Neurovascular Research · doi:10.2174/156720207779940662 · Cited by 16
Rajappa, M., Ikkruthi, S., Nandeesha, H., et al. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.02.030 · Cited by 16
Al-Azzam, S. I., Alkhateeb, A. M., Alzoubi, K. H., Alzayadeen, R. N., Ababneh, M., & Khabour, O. F. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1347 · Cited by 16
A cross‐sectional study of osteocalcin and body fat measures among obese adolescents
Lenders, C. M., Lee, P., Feldman, H. A., Wilson, D. M., Abrams, S. H., Gitelman, S. E., Klish, W. J., Wertz, M. S., Taylor, G. A., Alongi, R. T., et al. (2013) · Obesity · doi:10.1002/oby.20131 · Cited by 16
Hu, C., Zhang, R., Wang, C., et al. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-3 · Cited by 16
Boumaiza, I., Omezzine, A., Rejeb, J., Rebhi, L., Kalboussi, N., Rejeb, N. B., Nabli, N., Abdelaziz, A. B., Boughazala, E., & Bouslama, A. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0006 · Cited by 16
Lin, J.-D., Hsu, C.-H., Liang, Y.-J., Lian, W., Hsieh, C.-H., Wu, C.-Z., Pei, D., & Chen, Y.-L. (2015) · International Journal of Endocrinology · doi:10.1155/2015/675245 · Cited by 13
Narumi, T., Shishido, T., Kiribayashi, N., Kadowaki, S., Nishiyama, S., Takahashi, H., Arimoto, T., Miyashita, T., Miyamoto, T., Watanabe, T., et al. (2012) · Experimental Diabetes Research · doi:10.1155/2012/815098 · Cited by 16
Borai, A., Livingstone, C., Ghayour‐Mobarhan, M., Abuosa, A. M., Shafi, S., Mehta, S., Heidari, A., Emadzadeh, A., Wark, G., & Ferns, G. A. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.010 · Cited by 16
Metwalley, K. A., & El-Saied, A.-R.-H. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.131169 · Cited by 16
Juárez-Meavepeña, M., Carreón‐Torres, E., López-Osorio, C., García-Sánchez, C., Gamboa, R., Torres‐Tamayo, M., Fragoso, J. M., Rodrı́guez-Pérez, J. M., Vargas‐Alarcón, G., & Pérez-Méndez, O. A. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0071 · Cited by 16
Neri, S., Signorelli, S. S., Scuderi, R. T., Bruno, M., Bertino, G., Clementi, A., Torrisi, I., Fidone, F., Pagano, A. B., Malaguarnera, M., et al. (2011) · International Journal of Angiology · doi:10.1055/s-0031-1283218 · Cited by 16
Shen, Q., Bergquist‐Beringer, S., & Sousa, V. D. (2010) · Biological Research For Nursing · doi:10.1177/1099800410384501 · Cited by 16
Marchetti, G., Girelli, D., Zerbinati, C., Lunghi, B., Friso, S., Meneghetti, S., Coen, M., Gagliano, T., Guastella, G., Bochaton‐Piallat, M., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-05-0466 · Cited by 16
Aydın, E., & Özkökeli, M. (2014) · Brazilian Journal of Cardiovascular Surgery · doi:10.5935/1678-9741.20140105 · Cited by 15
Cellik-Guzel, E., Bakkal, E., Güzel, S., Eroglu, H. E., Acar, A., Topçu, B., & Küçükyalçın, V. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s72087 · Cited by 16
Assessment of β-cell function in human patients
Choi, C. S., Kim, M. Y., Han, K., & Lee, M. (2012) · Islets · doi:10.4161/isl.19270 · Cited by 17
Bhowmik, B., Munir, S. B., Ahmed, K. R., Siddiquee, T., Diep, L. M., Wright, E., Hassan, Z., Debnath, P. R., Mahtab, H., Khan, A. K. A., et al. (2013) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2013.06.001 · Cited by 16
Yachi, Y., Tanaka, Y., Anasako, Y., Nishibata, I., Saito, K., & Sone, H. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.02.012 · Cited by 16
Chen, P., Huang, M., Chiu, C.-C., Liu, H., Lu, M., & Chen, C.-H. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.07.014 · Cited by 16
Gender dimorphic increase in RBP ‐4 and NGAL in children born after IVF : an epigenetic phenomenon?
Sakka, S. D., Margeli, A., Loutradis, D., Chrousos, G. P., Papassotiriou, I., & Kanaka‐Gantenbein, C. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12066 · Cited by 16
Simental‐Mendía, L. E., Castañeda-Chacón, A., Rodríguez‐Morán, M., Aradillas-García, C., & Guerrero‐Romero, F. (2014) · European Journal of Pediatrics · doi:10.1007/s00431-014-2426-z · Cited by 15
Çağlar, G. S., Öztaş, E., Karadağ, D., et al. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.08.024 · Cited by 16
Rachmani, R., Shenhav, G., Slavachevsky, I., Levy, Z., & Ravid, M. (2004) · Blood Pressure Monitoring · doi:10.1097/00126097-200404000-00002 · Cited by 16
Blatter, M. F. C., del Prado, B., Miceli, D. D., Gomez, N., Ivanic, J., Ditollo, B., Gallelli, M. F., & Castillo, V. A. (2012) · Research in Veterinary Science · doi:10.1016/j.rvsc.2012.02.003 · Cited by 16
Pereira, I. B., Sampaio, H. A. D. C., Carioca, A. A. F., et al. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003296 · Cited by 16
Benardeau, A. M., Verry, P., Atzpodien, E., Funk, J., Meyer, M., Mizrahi, J. L., Winter, M., Wright, M. B., Uhles, S., & ŠEBÖKOVÁ, E. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12006 · Cited by 16
Goday, A., Gabriel, R., Ascaso, J. F., Franch, J., Ortega, R., Martínez, O., & Lerones, N. (2008) · Revista Clínica Española · doi:10.1157/13126339 · Cited by 15
Gaillard, T. R., Sherman, W. M., Devor, S. T., Kirby, T. E., & Osei, K. (2007) · Nursing Research · doi:10.1097/01.nnr.0000299851.67676.34 · Cited by 16
Silva, A. P., Fragoso, A., Pinho, A., Tavares, N., Camacho, A., Faísca, M., & Neves, P. L. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.02.007 · Cited by 14
Li, J., Wu, N., Li, Y., Ye, K., He, M., & Hu, R. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0200-9 · Cited by 16
Gender modulates development of the metabolic syndrome phenotype in fructose-fed rats
Korićanac, G., Djordjevic, A. D., Žakula, Z., et al. (2013) · Archives of Biological Sciences · doi:10.2298/abs1302455k · Cited by 16
Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1–3
Wang, C., Bao, X.-R., Guo-wei, D., et al. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0720-3 · Cited by 16
Vlaar, E. M., Nierkens, V., Nicolaou, M., et al. (2014) · Public Health Nutrition · doi:10.1017/s1368980014001086 · Cited by 16
Ohuchi, H., Negishi, J., Hayama, Y., Sasaki, O., Taniguchi, Y., Noritake, K., Miyazaki, A., & Yamada, O. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.02.026 · Cited by 16
Chou, Y., Sheu, W. H., Tang, Y., Chen, Y., Liao, S., Chuang, Y., Lin, C., & Chen, D. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(09)70012-3 · Cited by 16
Oguri, K., Tachi, T., & Matsuoka, T. (2013) · Acta Paediatrica · doi:10.1111/apa.12149 · Cited by 16
Oliveira, A. C., Parise, E. R., Catarino, R. M., Lanzoni, V. P., Leite-Mor, M. M. B., Simon, K., & Junqueira, V. B. C. (2009) · Free Radical Research · doi:10.3109/10715760903247249 · Cited by 16
Lee, K.-Y., Kang, H., & Shin, Y. (2012) · Gene · doi:10.1016/j.gene.2012.12.028 · Cited by 16
Serologic predictors of nonalcoholic steatohepatitis in a population undergoing bariatric surgery
Chisholm, J. A., Seki, Y., Toouli, J., Stahl, J., Collins, J., & Kow, L. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.06.010 · Cited by 16
Usui, S., Ichimura, M., Ikeda, S., et al. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.08.017 · Cited by 16
Fat feeding potentiates the diabetogenic effect of dexamethasone in Wistar rats
Sivabalan, S., Renuka, S., & Menon, V. P. (2008) · International Archives of Medicine · doi:10.1186/1755-7682-1-7 · Cited by 17
Lack of Association of –55CT Polymorphism of UCP3 Gene with Fat Distribution in Obese Patients
de Luis, D. A., Aller, R., Izaola, O., et al. (2007) · Annals of Nutrition and Metabolism · doi:10.1159/000107685 · Cited by 16
Esteghamati, A., Zandieh, A., Zandieh, B., Khalilzadeh, O., Meysamie, A., Nakhjavani, M., & Gouya, M. M. (2011) · Endocrine · doi:10.1007/s12020-011-9447-4 · Cited by 16
Tumor necrosis factor alpha and its soluble receptors in obese children with NAFLD
Lebensztejn, D. M., Kowalczuk, D., Tarasów, E., Skiba, E., & Kaczmarski, M. G. (2010) · Advances in Medical Sciences · doi:10.2478/v10039-010-0008-5 · Cited by 16
Kaya, C., Pabuçcu, R., Koca, C., Oğuz, A. K., Erkan, A. F., Korkmaz, A., & Erbaş, D. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.05.055 · Cited by 16
Martínez-García, M. Á., San‐Millán, J. L., & Escobar-Morreale, H. F. (2012) · Gene · doi:10.1016/j.gene.2012.01.047 · Cited by 16
Serum triglycerides as a marker of insulin resistance in non-diabetic urban Indians
Snehalatha, C., Satyavani, K., Sivasankari, S., et al. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.021 · Cited by 16
Hepatic steatosis, carotid atherosclerosis and metabolic syndrome: the STEATO Study
Carallo, C., Mancuso, G., Mauro, G. F., et al. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0125-8 · Cited by 16
Jouret, B., Dulac, Y., Bassil, R., Taktak, A., Cristini, C., Lounis, N., Molinas, C., Salles, J., Arnaud, C., Acar, P., et al. (2011) · Hormone Research in Paediatrics · doi:10.1159/000329379 · Cited by 16
The Role of Norepinephrine and Insulin Resistance in an Early Stage of Hypertension
Penesová, A., Rádiková, Ž., Cizmárová, E., Květňanský, R., Blazicek, P., Vlček, M., Koška, J., & Vigas, M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1410.036 · Cited by 16
Pontiroli, A. E., Gniuli, D., & Mingrone, G. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0076-4 · Cited by 16
High Normal Urine Albumin-to-Creatinine Ratio Predicts Development of Hypertension in Korean Men
Park, S. K., Moon, S. Y., Oh, C., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0745 · Cited by 16
Contribution of Zinc Deficiency to Insulin Resistance in Patients with Primary Biliary Cirrhosis
Himoto, T., Yoneyama, H., Kurokochi, K., et al. (2011) · Biological Trace Element Research · doi:10.1007/s12011-011-9049-2 · Cited by 16
Weight Change as a Predictor of Incidence and Remission of Insulin Resistance
Chang, Y., Sung, E., Yun, K. E., Jung, H. S., Kim, C., Kwon, M., Cho, S., & Ryu, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063690 · Cited by 16
Li, N., Guo, Y., Hongmei, W., Zhi-tao, Y., Juhong, Z., Ling, Z., & Wen-li, L. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.08.006 · Cited by 16
Zhang, C., & Zhang, R. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.01.003 · Cited by 17
Gonzalez, J. T., Green, B. P., Campbell, M. D., Rumbold, P. L. S., & Stevenson, E. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.41 · Cited by 16
Establishment of a cut‐point value of serum TNF‐α levels in the metabolic syndrome
Gurrola‐Díaz, C. M., Sánchez‐Enríquez, S., Oregon‐Romero, E., García‐López, P. M., de la Mora, P. G., Bastidas‐Ramírez, B. E., González-Hita, M. E., & Muñóz-Valle, J. F. (2009) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20289 · Cited by 15
Welin, L., Bresäter, L. E., Eriksson, H., et al. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/00149831-200308000-00011 · Cited by 16
Glyco-metabolic profile among type 2 diabetic patients with erectile dysfunction
Derosa, G., Tinelli, C., D’Angelo, A., Ferrara, G., Bonaventura, A., Bianchi, L., Romano, D., Fogari, E., & Maffioli, P. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0117 · Cited by 15
Nakatochi, M., Miyata, S., Tanimura, D., Izawa, H., Asano, H., Murase, Y., Kato, R., Ichihara, S., Naruse, K., Matsubara, T., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.02.029 · Cited by 16
Das, S., Bennett, A. J., Sovio, U., Ruokonen, A., Martikainen, H. K., Pouta, A. M., Hartikainen, A., Franks, S., Elliott, P., Poulton, J., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0702 · Cited by 16
Torun, E., Gökçe, S., Özgen, İ. T., et al. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0337 · Cited by 16
de Matthaeis, A., Greco, A., Serviddio, G., Stramaglia, G., & Vendemiale, G. (2010) · Aging Clinical and Experimental Research · doi:10.1007/bf03337727 · Cited by 16
Bendlová, B., Vejražková, D., Včelák, J., et al. (2008) · Physiological Research · doi:10.33549/physiolres.931492 · Cited by 16
Severity of coronary artery disease in postmenopausal diabetic women
Saltiki, K., Cimponeriu, A., Lili, K., Peppa, Μ., Anastasiou, E., & Alevizaki, M. K. (2008) · HORMONES · doi:10.1007/bf03401506 · Cited by 16
Ghrelin as a potential blood pressure reducing factor in obese women during weight loss treatment.
Mizia‐Stec, K., Zahorska‐Markiewicz, B., Olszanecka‐Glinianowicz, M., et al. (2008) · PubMed · Cited by 16
Fahy, S. J., Sun, C., Zhu, G., Healey, P. R., Spector, T. D., Martin, N. G., Mitchell, P., Wong, T. Y., Mackey, D. A., Hammond, C. J., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5927 · Cited by 16
Muscle glucose uptake is effectively activated by ischemia in type 2 diabetic subjects.
Niklasson, M., Holmäng, A. B., Sjöstrand, M., Strindberg, L., & Lönnroth, P. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1178 · Cited by 16
Both a traditional and modified Daniel Fast improve the cardio-metabolic profile in men and women
Alleman, R. J., Harvey, I. C., Farney, T. M., & Bloomer, R. J. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-114 · Cited by 16
Park, E. (2010) · Nutrition Research and Practice · doi:10.4162/nrp.2010.4.4.311 · Cited by 15
Beydoun, M. A., Nalls, M. A., Canas, J. A., et al. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514001706 · Cited by 16
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
